Interviewee: Eric Lander.
Eric Lander, director of the Whitehead Institute Center for Genome Research, speaks about the private project and the role technology played.
(DNAi Location: Genome > The Project > Players >Technology > Sequencers enabled both projects)
The interesting thing about the Celera announcement was that so much was made about some new strategy. But of course it wasn't about a new strategy, the real heroes of this were the people at Applied Biosystems who developed the new capillary sequencer. The secret of all of this was the availability of a new capillary sequencer, and once it became clear that the new sequencer was going to be available on schedule it was a very simple thing to do, just buy a bunch of those sequencers.